or
forgot password
  • cancer clinical trials in rochester, NY

  • Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Lipson Cancer and Blood Center at Rochester General Hospital
    University Radiation Oncology at Parkridge Hospital
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
    Highland Hospital of Rochester

    Trial Locations
    Highland Hospital of Rochester
    Lipson Cancer and Blood Center at Rochester General Hospital
    University Radiation Oncology at Parkridge Hospital
    Prostate Cancer
    Vascular CT Assessment of Structural Autograft and Allograft Healing
    University of Rochester
    Rochester, New York 14642
    Bone Tumors
    Phase II Sunitinib Prog Met AIPC
    Interlakes Oncology Hematology, PC
    Rochester, New York 14623
    Metastatic Prostate Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    University of Rochester
    Rochester, New York 14642
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    University of Rochester
    Rochester, New York 14642
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
    University of Rochester

    Trial Locations
    University of Rochester
    Interlakes Foundation Inc-Rochester
    Highland Hospital
    Stage IV Pancreatic Cancer
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    University of Rochester Medical Center
    Rochester, New York 14642
    Hepatic Veno-Occlusive Disease
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    University Radiation Oncology at Parkridge Hospital
    Lung Cancer
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    University of Rochester
    Rochester, New York 14642
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Interlakes Oncology Hematology, PC
    Rochester, New York 14623
    Androgen-independent Prostate Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Colorectal Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Highland Hospital
    Rochester, New York 14620
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    FTY720 in Patients With Primary Progressive Multiple Sclerosis
    University of Rochester Medical Center
    Rochester, New York 14642
    Primary Progressive Multiple Sclerosis
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    University of Rochester
    Rochester, New York 14642
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    University of Rochester
    Rochester, New York 14642
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lung Cancer
    S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma
    Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer
    University of Rochester Medical Center
    Rochester, New York 14642
    Prostate Cancer
    Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
    NMDP Northeast District - Greater NY State Office
    Rochester, New York 14607
    Healthy
    RCT of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities
    University of Rochester School of Medicine and Dentistry
    Rochester, New York 14642
    Colorectal Neoplasms
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    University of Rochester
    Rochester, New York 14642
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Burden of Cancer in Children: A Pilot Study to Investigate the Impact and Content of Video Illness Narratives
    University of Rochester School of Medicine and Dentistry, Galisano Children's Hospital at Strong
    Rochester, New York 14642
    Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    University Radiation Oncology at Parkridge Hospital
    Endometrial Cancer, Fatigue, Neurotoxicity
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    University of Rochester

    Trial Locations
    University of Rochester
    Interlakes Foundation Inc-Rochester
    Highland Hospital
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Screening for Bladder Cancer
    University of Rochester Medical Center
    Rochester, New York 14642
    Bladder Cancer
    A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma
    University of Rochester Medical Center
    Rochester, New York 14642
    Disease, Hodgkin
    Exercise for Breast Cancer Patients (EXCAP)
    James P. Wilmot Cancer Center, University of Rochester
    Rochester, New York 14642
    Fatigue
    S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Highland Hospital of Rochester
    Rochester, New York 14620
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia, Lymphoma
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
    University of Rochester Medical Center

    Trial Locations
    University of Rochester Medical Center
    Rochester General Hospital
    Venous Thromboembolism, Pulmonary Embolism
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Highland Hospital

    Trial Locations
    Highland Hospital
    University Radiation Oncology
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma